Login / Signup

CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders.

Marta H HernándezValentin BoteAlexandre Serra-LLovichMarc CendrosJuliana SalazarConcepción MestresSilvina GuijarroAida AlvarezCristina LamborenaIria MendezBernardo SanchezAmaia HervasMaría Jesús Arranz
Published in: Pharmacogenomics and personalized medicine (2022)
CES1 genetic variants may influence the clinical outcome of MPH treatment in ASD comorbid with ADHD children and adolescents.
Keyphrases
  • autism spectrum disorder
  • attention deficit hyperactivity disorder
  • intellectual disability
  • working memory
  • combination therapy